Olink

Olink®
Part of Thermo Fisher Scientific

Documents

Access a comprehensive collection of resources, including brochures, infographics, user manuals, validation data, technical notes, and white papers. Easily filter by document type, application, research area, and products to find the specific information you need.

Filters

DocumentsDocument typeApplicationResearch areaProduct

Data normalization and standardization

This paper describes Olink®’s built-in QC system, NPX calculation and definition, and the different normalization methods we use.

Registration required

Designing Non-Terminal Longitudinal Mouse Studies

Registration required

Development and validation of customized PEA biomarker panels with clinical utility

This describes how PEA can be applied to the development and validation of lower-plex assays that could help to translate protein signatures from discovery to clinical utility.

Registration required

Discovering more with less

Registration required

Empowering genomics with high-throughput proteomics

Registration required

Ensuring quality with flexibility- Olink® Flex validation & verification

This white paper transparently presents some of the results from our verification and validation tests carried out during the development of Olink® Flex.

Registration required

Insights into clinical applications of protein signatures

Registration required

Insights into cytokine storm research with circulating biomarkers (long)

Registration required

Insights into cytokine storm research with circulating biomarkers (short)

Registration required

Insights into immuno-oncology research

Registration required

Insights into pharmacokinetics and pharmacodynamics studies

Registration required

Insights into Th cytokine profiling in disease research

Registration required

Insights into the predictive value of blood IFN signature in cancer

Registration required

Measuring protein biomarkers with Olink® - technical comparisons and orthogonal validation

This white paper addresses how data from Olink® studies compares to other technologies. We present examples of comparisons ranging from single-plex ELISAs to high multiplex assays and also provide useful tips for comparisons between Olink® data and data from other technologies.

Registration required

Multiple analysis of inflammatory proteins: a comparative study across multiple platforms

This study compared the Olink® Target 48 Cytokine head-to-head with two commonly used commercial multiplex proteomics platforms, as well as to Olink® Explore 1536.

Registration required

Multiple analysis of inflammatory proteins: a comparative study across multiple platforms - APPENDIX

Additional comparative data from the study described in the original white paper.

Registration required

Olink Target 48 Mouse Cytokine comprehensive product brochure

Registration required

PEA- a high-multiplex immunoassay technology with qPCR or NGS readout

A short overview of how the unique technology behind Olink®’s biomarker panels with NGS or qPCR readout works and how it overcomes the problems normally associated with multiplexed immunoassays.

Registration required

PEA: Exceptional specificity in a high multiplex format

This white paper highlights Olink’s PEA technology’s exceptional specificity in multiplex protein analysis, emphasizing its rigorous validation, minimal cross-reactivity, and superior accuracy. It showcases genetic validation and its applications in various disease contexts.

Registration required

Performance Comparison of Assays Usable for FDA Project Optimus

Registration required

189 documents